Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Insulin Eye Drops for Corneal Epithelial Wound Healing After Cross-linking in Keratoconus
NCT07812129Phase 3Completed
- Sponsor
- Cairo University
- Start
- Nov 2023
- Primary completion
- May 2025
- Countries
- 1
01
Overview
Phase 3, randomised trial of human insulin in corneal epithelial defect (2 arms), sponsored by Cairo University. Primary endpoint: Corneal epithelial wound healing at 7 days. Started Nov 2023; status: completed.
02
Drugs
human insulin
03
Conditions
corneal epithelial defect
Beyond the preview
Go deeper on NCT07812129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07812129.